Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
5.6M
-
Shares change
-
+112K
-
Total reported value, excl. options
-
$168M
-
Value change
-
+$3.06M
-
Number of buys
-
28
-
Number of sells
-
-39
-
Price
-
$30.06
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2022
88 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q3 2022.
IRADIMED CORP - Common Stock (IRMD) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.6M shares
of 12.7M outstanding shares and own 43.99% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (726K shares), Soleus Capital Management, L.P. (685K shares), RENAISSANCE TECHNOLOGIES LLC (627K shares), BlackRock Inc. (403K shares), VANGUARD GROUP INC (383K shares), RK Capital Management, LLC (352K shares), Russell Investments Group, Ltd. (258K shares), Bares Capital Management, Inc. (224K shares), Ranger Investment Management, L.P. (196K shares), and ACADIAN ASSET MANAGEMENT LLC (166K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.